Structured evidence table for Saw Palmetto Urinary Symptoms Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Saw Palmetto Urinary Symptoms Randomized Trial | This systematic review assessed the potential effectiveness and safety of Serenoa repens (saw palmetto) for benign prostatic disorders, mainly benign prostatic hyperplasia and associated lower urinary tract symptoms. | 1 | Schwartzmann I (2026) | Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence. |
| Saw Palmetto Urinary Symptoms Randomized Trial | repens was associated with improvements in symptom severity (International Prostate Symptom Score) in several trials, with variable effects on urinary flow, post-void residual volume, and patient-reported quality of life. | 1 | Schwartzmann I (2026) | Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence. |
| Saw Palmetto Urinary Symptoms Randomized Trial | Following PRISMA guidance (PROSPERO: CRD420251032255), we searched PubMed, Cochrane and ScienceDirect for human studies from January 2020 to May 2025. | 1 | Schwartzmann I (2026) | Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence. |
| Saw Palmetto Urinary Symptoms Randomized Trial | Conclusions : Although this study was a pilot study with a limited cohort, these findings provide preliminary evidence for the use of SAGX as a functional ingredient for supporting urinary health in men with LUTS. | 2 | Kim EY (2026) | Efficacy and Safety of <i>Salvia miltiorrhiza</i> Extract (SAGX) Compared with Saw Palmetto in Men with Lower Urinary Tract Symptoms: A 12-Week, Randomized, Double-Blind, Parallel-Group Pilot Study. |
| Saw Palmetto Urinary Symptoms Randomized Trial | Background: Lower urinary tract symptoms (LUTS) are prevalent among aging men and negatively affect quality of life. | 2 | Kim EY (2026) | Efficacy and Safety of <i>Salvia miltiorrhiza</i> Extract (SAGX) Compared with Saw Palmetto in Men with Lower Urinary Tract Symptoms: A 12-Week, Randomized, Double-Blind, Parallel-Group Pilot Study. |
| Saw Palmetto Urinary Symptoms Randomized Trial | Salvia miltiorrhiza extract (SAGX), which exhibits anti-inflammatory and antioxidant properties, has been developed as a functional ingredient to improve LUTS. | 2 | Kim EY (2026) | Efficacy and Safety of <i>Salvia miltiorrhiza</i> Extract (SAGX) Compared with Saw Palmetto in Men with Lower Urinary Tract Symptoms: A 12-Week, Randomized, Double-Blind, Parallel-Group Pilot Study. |
Source documents